ABT
ABT Research
Abbott Laboratories
2.77%
Forward yield
$2.520 / yr per share
Yield percentile (5y)
P 100
1.4% (P10)1.7% (med)2.0% (P90)
Quality score
85/100
Strong · Moderate payout risk
Annual / share
$2.520
Quarterly · next ex-date 07-15 (39d)
vs 5y P90 reference
-32%
$91.07 vs $120.35 (5y P90 price)
Refreshed 2026-06-06Data coverage High — 44y history
01Fundamentals
ABT is a premier dividend growth stock for income investors, showcasing 44 consecutive years of payments and a safe 67.23% payout ratio. Despite a 2.6878% dividend yield below passive rates, its robust 11.24% 5-year dividend growth and $7.395B in Free Cash Flow support compelling long-term income appreciation.
Bull caseABT demonstrates exceptional dividend commitment with 44 consecutive years of payments and strong 11.24% 5-year dividend growth, backed by a robust $7.395B in Free Cash Flow.
Bear caseThe 2.6878% dividend yield offers less current income than passive alternatives, despite a robust 12.334% ROE and a healthy 64.773% Debt/Equity.
02Risk & quality
| GAAP payout ratio | Moderate · 67.2% |
| Overall quality score | 85 / 100 · Strong |
Score breakdown — five dimensions, each /2020 + 20 + 18 + 8 + 10 = 85
20.0/20
Consistency
20.0/20
Payout safety
17.6/20
Moat
↓
7.5/20
Growth rate
9.8/20
Balance sheet
- Consistency 20.0/20 — ABT has raised or maintained its dividend for 44 consecutive years, qualifying as a Dividend Aristocrat (25+ year streak). The dimension caps at 10 years, so 44 years comfortably clears the ceiling for full credit.
- Payout safety 20.0/20 — ABT pays out 67.2% of GAAP earnings as dividends — still inside the safe band, with some headroom before reaching 80%, the level commonly flagged as strained. Manageable as long as earnings hold up.
- Moat 17.6/20 — Scores how protected ABT's earnings stream is from competition. Operating in Healthcare, ABT benefits from the kind of brand pricing power, regulatory position, or scale that lets margins hold up through economic cycles. Cyclical or commodity-driven sectors typically score in the single digits here.
- Growth rate 7.5/20 — ABT's dividend grew about 11.2% per year over 5 years — solid by absolute standards, but a notch below the 15-20% pace seen at growth-oriented dividend payers (think SCHD constituents). Familiar pattern for established staples already paying out most of what they earn — the runway for further hikes naturally narrows once payout ratios climb.
- Balance sheet 9.8/20 — A composite of ROE and inverse leverage. A low score here can mean weak return-on-equity, high debt, or both — for ABT, 12.3% ROE and 65% debt-to-equity. Doesn't directly threaten the current dividend if cash flow is healthy, but it does limit how much room the company has for future hikes or to absorb a downturn.
03Price reference
$10,000at current price →$277/ yr in dividends
Math: 2.77% forward yield. Historical 5y DGR is 11.2%/yr — past growth does not guarantee future results.
Below are statistical price references from the last 5 years of trading, anchored to historical drawdown events. They describe where the price has been — not where it should be.
$88.42
$120.35
$91.07
5y P10
5y P90
Now
| Current price | $91.07 |
| 5y P90 reference (high-yield 10% tail) | $120.35 — -32.2% lower |
| 5y P10 reference (low-yield 10% tail) | $88.42 — 2.9% lower |
| 5y max observed yield (at P10 price) | 2.9% |
| Annual dividend (frozen forward) | $2.520 / share · 2.77% yield |
Historical price trough
Low $82.56 · drawdown 3227 days · yield reached 2.7%
Important — this is reference data, not investment advice.
Quality scores, percentiles, and price references are statistical summaries of historical data computed by our research methodology from public market data, refreshed daily. They do not constitute a buy / sell / hold recommendation, do not account for your personal financial situation, tax bracket, or goals, and past performance does not predict future results. Consult a registered investment advisor before making investment decisions. divcalc.io is not a registered investment advisor.
Quality scores, percentiles, and price references are statistical summaries of historical data computed by our research methodology from public market data, refreshed daily. They do not constitute a buy / sell / hold recommendation, do not account for your personal financial situation, tax bracket, or goals, and past performance does not predict future results. Consult a registered investment advisor before making investment decisions. divcalc.io is not a registered investment advisor.